The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AERIE PHARMACEUTICALS INC COM 00771V108 2,426 64,095 SH   SOLE   64,095 0 0
AMICUS THERAPEUTICS INC COM 03152W109 3,760 756,596 SH   SOLE   756,596 0 0
BIO-RAD LABRATORIES COM 090572207 3,339 18,318 SH   SOLE   18,318 0 0
CLOVIS COM 189464100 703 15,832 SH   SOLE   15,832 0 0
CENTENE CORP COM 15135B101 5,062 89,569 SH   SOLE   89,569 0 0
DAVITA COM 23918K108 1,249 19,451 SH   SOLE   19,451 0 0
EDWARDS LIFESCIENCES CORP COM 28176E108 956 10,200 SH   SOLE   10,200 0 0
ELI LILLY & CO COM 532457108 4,191 56,984 SH   SOLE   56,984 0 0
HMS HOLDINGS COM 40425J101 4,808 264,760 SH   SOLE   264,760 0 0
IMPAX LABORATORIES INC COM 45256B101 2,201 166,099 SH   SOLE   166,099 0 0
INCYTE CORP COM 45337C102 2,039 20,337 SH   SOLE   20,337 0 0
IRONWOOD PHARMACEUTICALS COM 46333X108 877 57,363 SH   SOLE   57,363 0 0
JAZZ PHARMACEUTICALS COM G50871105 4,644 42,597 SH   SOLE   42,597 0 0
NATERA COM 632307104 694 59,300 SH   SOLE   59,300 0 0
NEVRO CORP COM 64157F103 2,087 28,725 SH   SOLE   28,725 0 0
PERRIGO COM G97822103 861 10,339 SH   SOLE   10,339 0 0
PTC THERAPEUTICS COM 69366J200 5,287 484,579 SH   SOLE   484,579 0 0
QUEST DIAGNOSTICS COM 74834L100 2,710 29,485 SH   SOLE   29,485 0 0
SYNERGY PHARMACEUTICALS INC COM 871639308 3,380 555,085 SH   SOLE   555,085 0 0
UNITEDHEALTH GROUP INC COM 91324P102 2,506 15,659 SH   SOLE   15,659 0 0